EUVIMEDScopri EUVIMED
MetaanalyseSystematische Übersicht

Cardiovascular Outcomes of Drug‐Coated Balloon Versus Drug‐Eluting Stents for Femoropopliteal Peripheral Arterial Disease Interventions: A Meta‐Regression Analysis

Yasar Sattar, Mohammad Hamza iD, Mansi Oberoi, Neel Patel, Nouraldeen Manasrah, Yasemin Bahar, Rana Usman Anwar, Sadaf Fakhra, Shazia Aziz, Moinuddin Syed, Ramesh Daggubati, Vikrant Jagadeesan and 5 more

Catheterization and Cardiovascular Interventions · 2026-06 · 107 (7) · 2275-2286

DOI: 10.1002/ccd.70557 ↗

At a glance

Metaanalyse in Catheterization and Cardiovascular Interventions, published online on 2026-04-05. Written by Yasar Sattar and 16 co-authors. Institution: Department of Cardiology, West Virginia University, Morgantown, West Virginia, USA. Major MEDLINE topics: Angioplasty, Balloon, Cardiovascular Agents, Drug-Eluting Stents, Peripheral Arterial Disease. 36 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Outcomes comparing drug‐coated balloons (DCB) versus drug‐eluting stents (DES) have not been sufficiently studied in femoropopliteal peripheral arterial disease (PAD).

Aims

This meta‐analysis aims to compare outcomes of DES versus DCBs in femoropopliteal PAD and uses regression to rule out effect modifiers.

Methods

An online literature search was conducted using the Preferred Reporting Items for Systematic Review and Meta‐Analysis search strategy from inception till November 2022. STATA v.17 was used for statistical analysis to calculate odds ratios and for univariate meta‐regression to rule out effect modifiers, including baseline characteristics and comorbidities.

Results

A total of eight studies with 1261 patients underwent femoropopliteal peripheral arterial intervention (DCB, n = 670; DES, n = 591). There was no difference in the primary outcome of all‐cause mortality and primary patency at 1 year and 2 years between DCB and DES. One‐year clinically‐driven target lesion revascularization (CD‐TLR) was significantly lower in the DCB group (OR: 0.68; 95% CI = 0.47–0.98; p = 0.04); however, no significant difference was found in 2‐year CD‐TLR. Regarding secondary outcomes' analysis, major amputation, procedural success, and post‐procedure ankle‐brachial index (ABI) failed to reach statistical significance. Univariate meta‐regression results showed no effect modification based on demographics, comorbidities, and lesion characteristics ( p > 0.05) for all outcomes except 1‐year CD‐TLR and major amputation.

Conclusion

There was no significant difference in all‐cause mortality and primary patency between DCB and DES for up to 2 years. DCB was associated with lower CD‐TLR at 1 year, which was lost at 2 years of follow‐up.

Subjects

MeSH terms (MEDLINE)

Angioplasty, BalloonCardiovascular AgentsDrug-Eluting StentsPeripheral Arterial DiseaseVascular Access DevicesAgedAged, 80 and overFemaleHumansMaleMiddle AgedCoated Materials, BiocompatibleFemoral ArteryLimb SalvagePopliteal ArteryProsthesis DesignRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeVascular Patency

Author keywords

drug‐coated balloondrug‐eluting stentendovascular interventionfemoropopliteal diseaseperipheral artery diseaseperipheral intervention

Substances

Cardiovascular AgentsCoated Materials, Biocompatible

Authors and institutions

  • Department of Cardiology, West Virginia University, Morgantown, West Virginia, USA.
  • Department of Internal Medicine, Albany Medical Center, Albany, New York State, USA.
  • Department of Cardiology, University of Nebraska Medical Center, Omaha, New York State, USA.
  • Department of Internal Medicine, New York Medical College/Landmark Medical Center, Woonsocket, Rhode Island, USA.
  • Department of Cardiology, Medical College of Georgia, Augusta, Georgia, Augusta, Georgia, USA.
  • Wayne State University, Detroit, Michigan, USA.

ORCID profiles: Mohammad Hamza, Mamas A Mamas, Islam Y Elgendy, M Chadi Alraies

Cite

APA

Sattar, Y., Hamza, M., Oberoi, M., Patel, N., Manasrah, N., Bahar, Y., Anwar, R. U., Fakhra, S., Aziz, S., Syed, M., Daggubati, R., Jagadeesan, V., Paul, T. K., Mamas, M. A., Elgendy, I. Y., Banerjee, S., & Chadi Alraies, M. (2026). Cardiovascular Outcomes of Drug‐Coated Balloon Versus Drug‐Eluting Stents for Femoropopliteal Peripheral Arterial Disease Interventions: A Meta‐Regression Analysis. Catheterization and Cardiovascular Interventions, 107(7), 2275-2286. https://doi.org/10.1002/ccd.70557

Vancouver

Sattar Y, Hamza M, Oberoi M, Patel N, Manasrah N, Bahar Y, et al. Cardiovascular Outcomes of Drug‐Coated Balloon Versus Drug‐Eluting Stents for Femoropopliteal Peripheral Arterial Disease Interventions: A Meta‐Regression Analysis. Catheterization and Cardiovascular Interventions. 2026;107(7):2275-2286. doi:10.1002/ccd.70557

BibTeX
@article{Sattar2026,
  author = {Sattar, Yasar and Hamza, Mohammad and Oberoi, Mansi and Patel, Neel and Manasrah, Nouraldeen and Bahar, Yasemin and Anwar, Rana Usman and Fakhra, Sadaf and Aziz, Shazia and Syed, Moinuddin and Daggubati, Ramesh and Jagadeesan, Vikrant and Paul, Timir K and Mamas, Mamas A and Elgendy, Islam Y and Banerjee, Subhash and Chadi Alraies, M},
  title = {Cardiovascular Outcomes of Drug‐Coated Balloon Versus Drug‐Eluting Stents for Femoropopliteal Peripheral Arterial Disease Interventions: A Meta‐Regression Analysis},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  volume = {107},
  number = {7},
  pages = {2275--2286},
  doi = {10.1002/ccd.70557}
}
Start for free →